[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wound Care Market by Product (Dressings (Foam, Film, Hydrocolloid, Collagen, Alginate), Devices (NPWT, Debridement), Grafts, Matrices, Topical Agents, Sutures, Stapler), Wound (Traumatic, Diabetic Ulcers, Surgical, Burn), End User - Global Forecast to 2026

April 2021 | 263 pages | ID: W6E0BEBDAE5EN
MarketsandMarkets

US$ 8,150.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global wound care market is projected to reach USD 27.8 billion by 2026 from USD 19.3 billion in 2021, at a CAGR of 7.6% during the forecast period. Market growth is largely driven by factors such as the growing prevalence of chronic conditions resulting in chronic, surgical, acute, and traumatic wounds; increasing spending on chronic wounds; rising use of regenerative medicine in wound management; and technological advancements.

“The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period“

Based on products, the wound care market is segmented into advanced wound care products, surgical wound care products, and traditional wound care products. During the forecasted period, advanced wound care segment is expected to grow at a highest CAGR in the global wound care market. Advanced wound care products are increasingly being used as the first line of therapy, making it likely that they will cannibalize the share of the traditional wound care products market. The advantages of advanced wound care over traditional wound care are the key factors driving the growth of this market.

“Homecare Settings segment accounted for the highest CAGR”

Based on end users, the wound care market is segmented into hospitals & clinics, long-term care facilities, home care settings, and other end users. During the forecasted period, the home care settings segment is expected to register the highest CAGR in the global wound care market. However, hospitals & clinics segment accounted for the largest share in 2020. The large share of this segment can be attributed to factors such as the growing prevalence of surgical and chronic wounds; rising incidence of associated SSIs and HAIs; and the increasing incidence of burn injuries.

“Asia Pacific: The fastest-growing region in wound care market”

The Asia Pacific market is expected to witness the highest growth during the forecast period, primarily due to the increasing investments by governments and industries, growing incidence of chronic conditions, and rising awareness of wound care products.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
  • By Designation: C-level - 30%, D-level - 20%, and Others - 50%
  • By Region: North America - 36%, Europe - 25%, Asia Pacific - 27%, Latin America – 9%, and Middle East and Africa – 3%.
List of companies profiled in the report:
  • Smith & Nephew Plc (UK)
  • M?lnlycke Health Care AB (Sweden)
  • Baxter International (US)
  • 3M Company (US)
  • Integra LifeSciences Holdings Corporation (US)
  • ConvaTec Group Plc (UK)
  • Coloplast A/S (Denmark)
  • Medtronic Plc (Ireland)
  • Ethicon Inc. (US)
  • PAUL HARTMANN AG (Germany)
  • MiMedx Group (US)
  • DeRoyal Industries (US)
  • Organogenesis Holdings (US)
  • Kerecis (Iceland)
  • ACell (US)
  • Lohmann & Rauscher International GmbH & Co. (Germany)
  • Medela AG (Switzerland)
  • Talley Group (England)
  • Pensar Medical (US)
  • B. Braun Melsungen AG (Germany)
  • Cardinal Health Inc. (US)
  • Misonix (US)
  • Zimmer Biomet Holdings (US)
  • DermaRite Industries (US)
  • Medline Industries (US)
  • Advancis Medical LLC (UK)
  • MilLaboratories Pvt. Ltd. (India)
  • Welcare Industries Spa. (Italy)
  • Wuhan VSD Medical Science & Technology (China)
  • Haromed BVBA (Belgium)
Research Coverage:

This report provides a detailed picture of the global wound care market. It aims at estimating the size and future growth potential of the market across different segments, such as product, wound type, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound care market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and trends.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
FIGURE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 LIMITATIONS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
  2.2.1 SECONDARY DATA
    2.2.1.1 Key data from secondary sources
  2.2.2 PRIMARY DATA
    2.2.2.1 Key data from primary sources
    2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
  2.3.1 BOTTOM-UP APPROACH
    2.3.1.1 Segmental revenue estimation approach
FIGURE 4 BOTTOM-UP APPROACH: SEGMENTAL REVENUE ESTIMATION APPROACH
    2.3.1.2 Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
    2.3.1.3 CAGR projections
FIGURE 6 SUPPLY-SIDE ANALYSIS
  2.3.2 TOP-DOWN APPROACH
FIGURE 7 WOUND CARE MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19 HEALTH ASSESSMENT
2.7 COVID-19 ECONOMIC ASSESSMENT
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 9 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 10 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE WOUND CARE MARKET

3 EXECUTIVE SUMMARY

FIGURE 11 WOUND CARE MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 12 WOUND CARE MARKET, BY WOUND TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 WOUND CARE MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 WOUND CARE MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

4.1 WOUND CARE MARKET OVERVIEW
FIGURE 15 INCREASING DEMAND FOR ADVANCED WOUND PRODUCTS TO DRIVE MARKET GROWTH
4.2 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 FOAM DRESSINGS SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2020
4.3 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2021 VS. 2026
FIGURE 17 INPATIENT SETTINGS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.4 WOUND CARE MARKET, BY REGION (2021?2026)
FIGURE 18 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
  5.2.1 DRIVERS
    5.2.1.1 Growing prevalence of diseases & conditions affecting wound healing capabilities
      5.2.1.1.1 Growing geriatric population
      5.2.1.1.2 Increasing prevalence of diabetes
FIGURE 20 INCIDENCE OF DIABETES, BY REGION, 2015 VS. 2040 (MILLION CASES)
      5.2.1.1.3 High incidence of obesity
      5.2.1.1.4 Increasing number of surgical procedures across the globe
TABLE 1 PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED IN THE US
      5.2.1.1.5 Increasing number of traumatic wounds
    5.2.1.2 Increasing spending on chronic wounds
    5.2.1.3 Technological advancements
    5.2.1.4 Rising use of regenerative medicine in wound management
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of advanced wound care products
    5.2.2.2 Risks associated with the use of advanced wound care products
TABLE 2 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS
  5.2.3 OPPORTUNITIES
    5.2.3.1 Growth potential in emerging economies
TABLE 3 STRATEGIC DEVELOPMENTS IN THE ASIA PACIFIC
  5.2.4 TRENDS
    5.2.4.1 Acquisitions by leading companies in the market
    5.2.4.2 Focus on expanding the capabilities of current technologies and launching novel products
      5.2.4.2.1 Smart advanced wound care
      5.2.4.2.2 Color changing dressings
      5.2.4.2.3 Integration of nanotechnology in wound care products
      5.2.4.2.4 Novel wound assessment/measurement devices
5.3 IMPACT OF COVID-19 ON THE WOUND CARE MARKET
5.4 ECOSYSTEM ANALYSIS
FIGURE 21 WOUND CARE MARKET: ECOSYSTEM ANALYSIS
5.5 VALUE CHAIN ANALYSIS
FIGURE 22 WOUND CARE MARKET: VALUE CHAIN ANALYSIS OVERVIEW
  5.5.1 WOUND CARE MARKET: PROCESS-BASED VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 23 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS
5.7 PATENT ANALYSIS
FIGURE 24 WOUND CARE MARKET: PATENT ANALYSIS
5.8 PRICING ANALYSIS
TABLE 4 PRICES OF WOUND CARE PRODUCTS (2021)
5.9 PESTEL ANALYSIS
FIGURE 25 WOUND CARE MARKET: PESTEL ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
  5.10.1 THREAT FROM NEW ENTRANTS
  5.10.2 THREAT FROM SUBSTITUTES
  5.10.3 BARGAINING POWER OF BUYERS
  5.10.4 BARGAINING POWER OF SUPPLIERS
  5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 TRADE ANALYSIS
  5.11.1 TRADE ANALYSIS FOR SUTURES AND ADHESIVES
TABLE 5 IMPORT DATA FOR SUTURES & ADHESIVES, BY COUNTRY, 2016–2020 (USD THOUSAND)
TABLE 6 IMPORT DATA FOR SUTURES & ADHESIVES, BY COUNTRY, 2016–2020 (TONS)
5.12 REGULATORY GUIDELINES
  5.12.1 NORTH AMERICA
  5.12.2 EUROPE
  5.12.3 EMERGING MARKETS
5.13 YC – YCC SHIFT
FIGURE 26 YC – YCC SHIFT FOR THE WOUND CARE MARKET
5.14 MARKET DISRUPTION

6 WOUND CARE MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 7 WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 ADVANCED WOUND CARE PRODUCTS
TABLE 8 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 9 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
  6.2.1 ADVANCED WOUND DRESSINGS
TABLE 10 ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 11 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.2.1.1 Foam dressings
TABLE 12 FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 FOAM DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      6.2.1.1.1 Silicone dressings
        6.2.1.1.1.1 Silicone dressings are used for a large variety of wounds—a key factor driving market growth
TABLE 14 SILICONE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
      6.2.1.1.2 Non-silicone dressings
        6.2.1.1.2.1 Non-silicone dressings are very effective in scar removal and wound healing—a key factor driving market growth
TABLE 15 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.2 Hydrocolloid dressings
      6.2.1.2.1 Hydrocolloid dressings are cost-effective and promote a moist environment, which is a requirement for optimal healing
TABLE 16 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.3 Film dressings
      6.2.1.3.1 Non-absorbable nature of film dressings may limit their adoption to a certain extent
TABLE 17 FILM DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.4 Alginate dressings
      6.2.1.4.1 Alginate dressings are well-suited for pressure and diabetic foot ulcers
TABLE 18 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.5 Hydrogel dressings
      6.2.1.5.1 Hydrogel dressings are available in several forms for effective use
TABLE 19 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.6 Collagen dressings
      6.2.1.6.1 Favorable reimbursement scenario for collagen dressings is supporting the growth of this segment
TABLE 20 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.7 Hydrofiber dressings
      6.2.1.7.1 Hydrofiber dressings combine the properties of hydrocolloids and alginates
TABLE 21 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.8 Wound contact layers
      6.2.1.8.1 Wound contact layers protect wound beds from bacterial and fungal growth
TABLE 22 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.9 Superabsorbent dressings
      6.2.1.9.1 Superabsorbent dressings are used where adhesive dressings may cause damage
TABLE 23 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.1.10 Other advanced dressings
TABLE 24 OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.2.2 WOUND THERAPY DEVICES
TABLE 25 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 26 WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.2.2.1 Portable & conventional NPWT devices
      6.2.2.1.1 Growing adoption of single-use NPWT devices in homecare will drive market growth
TABLE 27 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.2.2 Debridement devices & accessories
      6.2.2.2.1 Development of novel technologies to support market growth
TABLE 28 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.2.2.3 Wound assessment & monitoring devices
      6.2.2.3.1 Potential cost-reducing capabilities of wound assessment and monitoring devices will boost their adoption
TABLE 29 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
    6.2.2.4 Other devices & accessories
TABLE 30 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.2.3 GRAFTS & MATRICES
    6.2.3.1 Grafts & matrices promote healing and wound closure
TABLE 31 GRAFTS & MATRICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.2.4 TOPICAL AGENTS
    6.2.4.1 Cost-effectiveness and ease of use in home care settings will drive the demand for topical agents
TABLE 32 TOPICAL AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 SURGICAL WOUND CARE PRODUCTS
TABLE 33 SURGICAL WOUND CARE PRODUCTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 34 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
  6.3.1 SUTURES
    6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures are key factors driving product adoption
TABLE 35 SUTURES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.3.2 STAPLERS
    6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage, resulting in higher product adoption
TABLE 36 STAPLERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.3.3 TISSUE ADHESIVES, SEALANTS, AND GLUES
TABLE 37 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 38 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2019–2026 (USD MILLION)
    6.3.3.1 Fibrin-based sealants
      6.3.3.1.1 Fibrin-based sealants provide better results than sutures, which has driven product demand
TABLE 39 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3.3.2 Collagen-based sealants
      6.3.3.2.1 Collagen-based products are used in surgical procedures as an adjunctive to hemostatic agents
TABLE 40 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
    6.3.3.3 Synthetic adhesives
      6.3.3.3.1 Synthetics have additional sealing properties than traditional staples—a key driving factor
TABLE 41 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 TRADITIONAL WOUND CARE PRODUCTS
TABLE 42 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.4.1 MEDICAL TAPES
    6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients—key advantages leading to high adoption of these products
TABLE 44 MEDICAL TAPES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.4.2 DRESSINGS
    6.4.2.1 Presence of a large patient population for pressure ulcers (in which dry dressings are extensively used) has ensured a sustained demand for these products
TABLE 45 DRESSINGS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
  6.4.3 CLEANSING AGENTS
    6.4.3.1 High risk of HAIs from open wounds will drive the market for cleansing agents
TABLE 46 TYPES OF CLEANSING AGENTS
TABLE 47 CLEANSING AGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 WOUND CARE MARKET, BY WOUND TYPE

7.1 INTRODUCTION
TABLE 48 WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
7.2 SURGICAL & TRAUMATIC WOUNDS
  7.2.1 RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET GROWTH
TABLE 49 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 DIABETIC FOOT ULCERS
  7.3.1 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH
TABLE 50 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 PRESSURE ULCERS
  7.4.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
TABLE 51 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 VENOUS LEG ULCERS
  7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH
TABLE 52 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 BURNS & OTHER WOUNDS
  7.6.1 HIGH INCIDENCE OF BURN INJURIES IN EMERGING COUNTRIES TO DRIVE MARKET GROWTH
TABLE 53 WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2019–2026 (USD MILLION)

8 WOUND CARE MARKET, BY END USER

8.1 INTRODUCTION
TABLE 54 WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS & CLINICS
TABLE 55 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2019–2026 (USD MILLION)
  8.2.1 INPATIENT SETTINGS
    8.2.1.1 Increasing hospital admissions due to chronic wounds and the rising incidence of hospital-acquired pressure ulcers are key drivers for the growth of this end-user segment
TABLE 57 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
  8.2.2 OUTPATIENT SETTINGS
    8.2.2.1 Increasing costs of inpatient care have shifted attention toward outpatient settings
TABLE 58 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 HOME CARE SETTINGS
  8.3.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE WILL ENSURE MARKET GROWTH IN THIS SEGMENT
TABLE 59 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 LONG-TERM CARE FACILITIES
  8.4.1 GROWTH IN THE GERIATRIC AND VULNERABLE POPULATIONS IS DRIVING THE DEMAND FOR BETTER LONG-TERM CARE
TABLE 60 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 OTHER END USERS
TABLE 61 WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2019–2026 (USD MILLION)

9 WOUND CARE MARKET, BY REGION

9.1 INTRODUCTION
TABLE 62 WOUND CARE MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT
TABLE 63 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 65 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.2.1 US
    9.2.1.1 Rising incidence of chronic diseases and diabetes is a major driver for the growth of the wound care market in the US
TABLE 66 US: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 US: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.2.2 CANADA
    9.2.2.1 Rising prevalence of diabetes to drive the growth of the wound care market in Canada
TABLE 68 INCIDENCE OF DIABETES IN CANADA, 2019 VS. 2029
TABLE 69 CANADA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 70 CANADA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 71 PREVALENCE OF DIABETES IN EUROPE, 2019 VS. 2045
TABLE 72 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 73 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 74 EUROPE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.1 GERMANY
    9.3.1.1 Large diabetic population has supported product development and commercialization efforts in Germany
TABLE 75 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 76 GERMANY: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.2 UK
    9.3.2.1 Increase in R&D activities to propel market growth in the UK
TABLE 77 UK: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 78 UK: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.3 FRANCE
    9.3.3.1 Growing geriatric population to drive market growth
TABLE 79 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 80 FRANCE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.4 RUSSIA
    9.3.4.1 Government focus on increasing diabetes awareness will favor market growth in Russia
TABLE 81 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 82 RUSSIA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.5 ITALY
    9.3.5.1 Growth in this market is driven by the improving quality and accessibility to medical care and technologies
TABLE 83 ITALY: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 84 ITALY: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.6 SPAIN
    9.3.6.1 Increasing life expectancies and the growing geriatric population will favor product demand in Spain
TABLE 85 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 86 SPAIN: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.3.7 REST OF EUROPE
TABLE 87 ROE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ROE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ROE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 ROE: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ROE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 ROE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 ROE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 94 ROE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 95 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
TABLE 96 ROE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT
TABLE 97 APAC: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 98 APAC: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 99 APAC: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.1 CHINA
    9.4.1.1 Rising incidence of diabetes to drive the market growth
TABLE 100 CHINA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 101 CHINA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.2 JAPAN
    9.4.2.1 Favorable regulations in Japan have resulted in increased product launches and commercialization
TABLE 102 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 103 JAPAN: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.3 INDIA
    9.4.3.1 Investments by international firms have supported market growth in India
TABLE 104 INDIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 105 INDIA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.4 AUSTRALIA
    9.4.4.1 Growing awareness of diabetes management will support market growth in Australia
TABLE 106 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 107 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.5 SOUTH KOREA
    9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for product development
TABLE 108 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 109 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.6 SINGAPORE
    9.4.6.1 Growing prevalence of diabetes is a major driver for the growth of the wound care market in Singapore
TABLE 110 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 111 SINGAPORE: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.4.7 REST OF ASIA PACIFIC
TABLE 112 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 113 ROAPAC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 ROAPAC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 115 ROAPAC: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 ROAPAC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 ROAPAC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 ROAPAC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 ROAPAC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
TABLE 121 ROAPAC: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 122 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 123 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 124 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.5.1 BRAZIL
    9.5.1.1 Brazil is one of the largest markets for healthcare in the Latin American region
TABLE 125 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 126 BRAZIL: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.5.2 MEXICO
    9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico
TABLE 127 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 128 MEXICO: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
  9.5.3 REST OF LATIN AMERICA
TABLE 129 ROLATAM: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 130 ROLATAM: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 ROLATAM: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 ROLATAM: FOAM DRESSINGS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 ROLATAM: WOUND THERAPY DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 ROLATAM: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 ROLATAM: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 136 ROLATAM: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 ROLATAM: WOUND CARE MARKET, BY WOUND TYPE, 2019–2026 (USD MILLION)
TABLE 138 ROLATAM: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
  9.6.1 RISING PREVALENCE OF CONDITIONS SUCH AS LEG ULCERS IS A POSITIVE INDICATOR FOR MARKET GROWTH
TABLE 139 MEA: WOUND CARE MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 140 MEA: WOUND CARE MARKET, BY END USER, 2019–2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
FIGURE 29 KEY STRATEGIES IN THE WOUND CARE MARKET
(JANUARY 2018–FEBRUARY 2021)
10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 30 REVENUE SHARE ANALYSIS, BY KEY PLAYER, 2020
10.3 MARKET SHARE ANALYSIS
  10.3.1 ADVANCED WOUND CARE MARKET SHARE ANALYSIS
FIGURE 31 ADVANCED WOUND CARE MARKET SHARE, BY KEY PLAYER, 2020
  10.3.2 NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET SHARE ANALYSIS
FIGURE 32 NPWT MARKET SHARE, BY KEY PLAYER, 2020
  10.3.3 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS
FIGURE 33 ADVANCED WOUND DRESSINGS MARKET SHARE, BY KEY PLAYER, 2020
  10.3.4 SURGICAL SUTURES MARKET SHARE ANALYSIS
FIGURE 34 SURGICAL SUTURES MARKET SHARE, BY KEY PLAYER, 2020
  10.3.5 DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS
FIGURE 35 DEBRIDEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020
  10.3.6 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET SHARE RANKING
TABLE 141 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET SHARE RANKING, BY COMPANY, 2020
10.4 COMPANY EVALUATION QUADRANT
  10.4.1 DEFINITION AND METHODOLOGY
  10.4.2 LIST OF EVALUATED VENDORS
    10.4.2.1 Stars
    10.4.2.2 Emerging leaders
    10.4.2.3 Pervasive players
    10.4.2.4 Participants
FIGURE 36 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2020)
  10.5.1 PROGRESSIVE COMPANIES
  10.5.2 RESPONSIVE COMPANIES
  10.5.3 STARTING BLOCKS
  10.5.4 DYNAMIC COMPANIES
FIGURE 37 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2020
10.6 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS
FIGURE 38 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE WOUND CARE MARKET
10.7 COMPETITIVE SCENARIO
  10.7.1 MARKET EVALUATION FRAMEWORK, JANUARY 2018–FEBRUARY 2021
  10.7.2 PRODUCT LAUNCHES & APPROVALS
TABLE 142 PRODUCT LAUNCHES & APPROVALS (JANUARY 2018–FEBRUARY 2021)
  10.7.3 DEALS
TABLE 143 DEALS (JANUARY 2018–FEBRUARY 2021)
  10.7.4 OTHER DEVELOPMENTS
TABLE 144 OTHER DEVELOPMENTS (JANUARY 2018–FEBRUARY 2021)

11 COMPANY PROFILES

11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, SWOT Analysis and Right to Win)*
  11.1.1 3M COMPANY
TABLE 145 3M COMPANY: BUSINESS OVERVIEW
FIGURE 39 3M COMPANY: COMPANY SNAPSHOT (2020)
  11.1.2 SMITH & NEPHEW PLC
TABLE 146 SMITH & NEPHEW PLC: BUSINESS OVERVIEW
FIGURE 40 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2020)
  11.1.3 CARDINAL HEALTH
TABLE 147 CARDINAL HEALTH: BUSINESS OVERVIEW
FIGURE 41 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
  11.1.4 MEDTRONIC PLC
TABLE 148 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
  11.1.5 B. BRAUN MELSUNGEN AG
TABLE 149 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 43 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
  11.1.6 BAXTER INTERNATIONAL INC.
TABLE 150 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 44 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
  11.1.7 M?LNLYCKE HEALTH CARE AB
TABLE 151 M?LNLYCKE HEALTH CARE AB: BUSINESS OVERVIEW
FIGURE 45 M?LNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2020)
  11.1.8 CONVATEC GROUP
TABLE 152 CONVATEC GROUP: BUSINESS OVERVIEW
FIGURE 46 CONVATEC GROUP: COMPANY SNAPSHOT (2020)
  11.1.9 PAUL HARTMANN AG
TABLE 153 PAUL HARTMANN AG: BUSINESS OVERVIEW
FIGURE 47 PAUL HARTMANN AG: COMPANY SNAPSHOT (2020)
  11.1.10 COLOPLAST A/S
TABLE 154 COLOPLAST A/S: BUSINESS OVERVIEW
FIGURE 48 COLOPLAST A/S: COMPANY SNAPSHOT (2020)
  11.1.11 ORGANOGENESIS HOLDINGS INC.
TABLE 155 ORGANOGENESIS HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 49 ORGANOGENESIS HOLDINGS INC.: COMPANY SNAPSHOT (2020)
  11.1.12 MIMEDX GROUP
TABLE 156 MIMEDX GROUP: BUSINESS OVERVIEW
FIGURE 50 MIMEDX GROUP: COMPANY SNAPSHOT (2020)
  11.1.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 157 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW
FIGURE 51 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2020)
  11.1.14 MISONIX
TABLE 158 MISONIX: BUSINESS OVERVIEW
FIGURE 52 MISONIX: COMPANY SNAPSHOT (2019)
  11.1.15 ZIMMER BIOMET HOLDINGS INC.
TABLE 159 ZIMMER BIOMET HOLDINGS INC.: BUSINESS OVERVIEW
FIGURE 53 ZIMMER BIOMET HOLDINGS INC.: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
  11.2.1 ETHICON INC.
  11.2.2 DEROYAL INDUSTRIES
  11.2.3 KERECIS
  11.2.4 ACELL
  11.2.5 LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG
  11.2.6 MEDELA AG
  11.2.7 TALLEY GROUP
  11.2.8 WELCARE INDUSTRIES SPA
  11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.
  11.2.10 PENSAR MEDICAL
  11.2.11 HAROMED BVBA
  11.2.12 DERMARITE INDUSTRIES LLC
  11.2.13 MEDLINE INDUSTRIES, INC.
  11.2.14 ADVANCIS MEDICAL LLC
  11.2.15 MIL LABORATORIES PVT. LTD.
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis and Right to Win might not be captured in case of unlisted companies.

12 APPENDIX

12.1 CASE STUDY ANALYSIS
  12.1.1 CASE STUDY 1
  12.1.2 CASE STUDY 2
12.2 ADDITIONAL INSIGHTS
TABLE 160 NORTH AMERICA: NEGATIVE PRESSURE INCISION MANAGEMENT MARKET, BY REGION, 2016–2023 (USD MILLION)
TABLE 161 US: NEGATIVE PRESSURE INCISION MANAGEMENT MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
12.3 DISCUSSION GUIDE
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS

The advanced wound care segment is expected to account for the largest share of XX% in the global wound care products market in 2014. The large share of this segment is attributed to its wide usage as a first line treatment for wounds. The active wound care segment is poised to grow at the highest CAGR of XX% from 2014 to 2019. This is attributed to the increasing number of advanced products being launched in the market.

The wound care therapy devices market consists of negative pressure wound therapy (NPWT) devices, pressure relief devices, electrical stimulation devices, ultra-violet devices, oxygen and hyperbaric oxygen equipment, whirlpool therapy devices, electromagnetic therapy devices, and ultrasound devices. The negative pressure wound therapy devices market is slated to witness a high growth due to the favorable reimbursement scenario for such devices prevailing in the market.

The global wound care market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership position in this market over the forecast period. The growth of the North American market is likely to be driven by factors such as government support for development of wound care products, rising aging population, large population with chronic wounds, and increasing number of surgical procedures. The European wound care market is estimated to be the second largest market. Factors such as the increasing number of diabetic population, launch of technologically advanced wound care products, and rising awareness for innovative wound care treatment are the key factors that are likely to drive the European wound care market in the next five years.

However, active wound care and therapy devices for hospital care settings accounted for a larger share (XX%) as active wound care treatments such as skin grafting procedures are primarily carried out at hospitals. Similarly, therapy devices such as negative pressure wound therapy (NPWT), hyperbaric oxygen, and ultraviolet radiation need to be handled by skilled healthcare professionals; hence, hospitals accounted for a major share in the market.



More Publications